$RHHBF News
Last published 1y ago
- 1y agoLLYNVOPFEAZN+3Eli Lilly shares drop after obesity pill shows modest late-stage trial resultsCNBCEli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight loss and diabetes drugs.
- 1y agoLLYBMYABBVNVS+2Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortagesCNBCIt's unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.
- 1y agoLLYBMYABBVNVS+1Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly’CNBCTrump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
- 1y agoLLYNOVO.B-DKNVOPFE+4Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changerCNBCThe trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.
- 2y agoRHHBFNVOLLYHealthy Returns: How competitive can Roche be in the weight loss drug market?CNBCRoche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
- 2y agoAMZNROG-CHRHHBFJNJ+1Roche alleges counterfeit diabetes medical devices were sold on AmazonCNBCCounterfeit diabetes test strips have been sold on Amazon and shipped to patients across the U.S., said biotech company Roche.
- 3y agoNVSNOV.N-CHRHHBFNovartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buybackCNBCNovartis raised its guidance and announced the buybacks as the Swiss drugmaker reported second-quarter earnings, which topped Wall Street's expectations.